Home › Funds › Citigroup Inc › STRO
Citigroup Inc position in STRO
SUTRO BIOPHARMA INC · Health Care
Latest position (Q2 2026)7.46K sh
Reported value held$247.54K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 42.51K | $803.00K | New |
| Q4 2021 | 72.94K | $1.08M | Add |
| Q1 2022 | 28.67K | $236.00K | Reduce |
| Q2 2022 | 3.94K | $21.00K | Reduce |
| Q3 2022 | 1.30K | $7.00K | Reduce |
| Q4 2022 | 43.69K | $353.05K | Add |
| Q1 2023 | 172.13K | $795.25K | Add |
| Q2 2023 | 18.98K | $88.25K | Reduce |
| Q3 2023 | 825 | $2.86K | Reduce |
| Q4 2023 | 8.67K | $37.21K | Add |
| Q1 2024 | 11.58K | $65.44K | Add |
| Q2 2024 | 19.19K | $56.22K | Add |
| Q3 2024 | 61.14K | $211.54K | Add |
| Q4 2024 | 63.92K | $117.62K | Add |
| Q1 2025 | 65.31K | $42.49K | Add |
| Q2 2025 | 28.53K | $20.37K | Reduce |
| Q3 2025 | 75.38K | $65.46K | Add |
| Q4 2025 | 1.04K | $12.07K | Reduce |
| Q1 2026 | 18.84K | $469.43K | Add |
| Q2 2026 | 7.46K | $247.54K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding STRO
- BlackRock Inc 1.12M sh · $37.27M · Q2 2026
- Balyasny Asset Management 711.16K sh · $23.61M · Q2 2026
- Geode Capital Management 389.69K sh · $12.94M · Q2 2026
- Millennium Management 365.97K sh · $12.15M · Q2 2026
- Point72 Asset Management 237.83K sh · $7.90M · Q2 2026
- UBS Group AG 208.51K sh · $6.92M · Q2 2026
- Two Sigma Investments 201.69K sh · $6.70M · Q2 2026
- Marshall Wace 175.25K sh · $5.82M · Q2 2026
- JPMorgan Chase & Co 159.63K sh · $5.32M · Q2 2026
- Goldman Sachs Group 149.22K sh · $4.95M · Q2 2026
- Vanguard Group 375.79K sh · $4.35M · Q4 2025
- Northern Trust Corp 125.93K sh · $4.18M · Q2 2026